In glioblastoma, overexpression of CD133 has been excessively linked to CSCs’ self-renewal and resistance towards temozolomide (TMZ) by the activation of c-Jun N-terminal kinase (JNK) signaling [20] and Notch/sonic hedgehog (SHH) pathways, respectively [21]. Here, PROM1 is linked to glioblastoma.